Company
Australia's medical device regulator, which approved the OncoSil device
Every investor coverage indicates participated in a round Therapeutic Goods Administration raised.
Companies Therapeutic Goods Administration acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Therapeutic Goods Administration. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Sydney biotech Promethean BioPharma has launched an OnMarket crowdfunding round to fund manufacturing, trials and its push for non-prescription status of its CBD pain tablet in Australia.
OncoSil Medical has raised $5.6m from three large existing shareholders to fund overseas and domestic launches of its radiation therapy, after winning TGA and FDA clearances for pancreatic and bile duct cancer use.
News roundup: hydrogen storage firm Provaris Energy lines up a $1 million placement, water monitor Eco Detection takes on Daniel Lambert as advisor, plus emissions figures, offshore wind licences and industry research.
Digital health company Eucalyptus has raised $50 million from existing backers, reportedly valuing it at $560 million, even as doctors and regulators question the prescription practices of its weight-loss brand Juniper.
Also SmartCompany·Startup Daily·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·Forbes Australia·Forbes Australia
Australian manufacturing roundup: Titomic raises via placement, H2X signs hydrogen MoU, Austal posts a loss, Aristocrat trials cashless gaming, IDT restructures, Bisalloy reports, BAE recruits, CDU launches TAFE.
Also @AuManufacturing
Manufacturing roundup covering Tritium's Nasdaq listing via SPAC merger, LAVO's NSW government grant, AnteoTech's regulator request, Osteopore's quarterly revenue, a JAT-Pinnacle dairy partnership, and 2021 Australian EV sales figures.